Avexitide Promising for Hypoglycemia After Weight Loss Surgery - Medscape
6/12/2022 12:00:00 AM2 years 10 months ago
by Miriam E. Tucker
by Miriam E. Tucker
The GLP-1 receptor antagonist reduced all levels of hypoglycemia, by different measures, and in patients who had undergone different bariatric surgery procedures.
Avexitide (Eiger Biopharmaceuticals), a first-in-class GLP-receptor blocker, significantly reduced hypoglycemia in patients with refractory post-bariatric hypoglycemia, new research finds. Post-ba… [+5486 chars]
full article...